Log in to save to my catalogue

Treatment of lupus nephritis: consensus, evidence and perspectives

Treatment of lupus nephritis: consensus, evidence and perspectives

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2783497364

Treatment of lupus nephritis: consensus, evidence and perspectives

About this item

Full title

Treatment of lupus nephritis: consensus, evidence and perspectives

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Rheumatology, 2023-04, Vol.19 (4), p.227-238

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Despite the continuing development of immunomodulatory agents and supportive care, the prognosis associated with lupus nephritis (LN) has not improved substantially in the past decade, with end-stage kidney disease still developing in 5–30% of patients within 10 years of LN diagnosis. Moreover, inter-ethnic variation in the tolerance of, clinical r...

Alternative Titles

Full title

Treatment of lupus nephritis: consensus, evidence and perspectives

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2783497364

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2783497364

Other Identifiers

ISSN

1759-4790

E-ISSN

1759-4804

DOI

10.1038/s41584-023-00925-5

How to access this item